Literature DB >> 8742061

Expression and co-cytokine function of murine thioredoxin/adult T cell leukaemia-derived factor (ADF).

H Blum1, M Röllinghoff, A Gessner.   

Abstract

Human ADF (adult T cell leukaemia-derived factor), an isoform of thioredoxin, promotes proliferation of certain human lymphoid cell lines and is involved in many thiol-dependent reducing reactions. To study functional aspects of the murine homologue, we established inducible overexpression of murine ADF in E. coli and a purification method which led to an apparently homogeneous 14 kDa protein. This recombinant ADF was tested in proliferation assays with murine Th2 cells (D10.G4.1) and CTLL-2 cells. In synergy with IL-2, IL-4, IL-7 and IL-9 ADF displayed co-cytokine activity. These proliferative effects were neutralized by an affinity-purified polyclonal rabbit anti-ADF antiserum. The effects of ADF were critically dependent on the presence of 2-mercaptoethanol. Bacterial thioredoxin had similar effects on the proliferation of murine T cells. Thus, the thiol-related reducing capacity of these proteins is essential for their growth promoting activity. As investigated at the levels of mRNA and protein in several murine cell clones and lines as well as in mouse tissues ADF is expressed ubiquitously. Finally it could be demonstrated by competitive PCR that in contrast to cytokine mRNAs (e.g. IL-4 and IL-13) the expression of ADF mRNA in murine Th2 clones and spleen cells is not influenced by stimulation of these cells through the T cell receptor complex. Murine ADF therefore represents a protein constitutively expressed in a wide variety of cells with the capacity to enhance the proliferative effect of several cytokines on murine T cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8742061     DOI: 10.1006/cyto.1996.0002

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  10 in total

1.  Modification of one epitope-flanking amino acid allows for the induction of friend retrovirus-specific CD8+ T cells by Adenovirus-based immunization.

Authors:  Philipp Gödel; Sonja Windmann; Kirsten K Dietze; Ulf Dittmer; Wibke Bayer
Journal:  J Virol       Date:  2012-08-29       Impact factor: 5.103

2.  Enhanced immunogenicity of a genetic chimeric protein consisting of two virulence antigens of Streptococcus mutans and protection against infection.

Authors:  Ping Zhang; Christina Jespersgaard; Leticia Lamberty-Mallory; Jannet Katz; Yan Huang; George Hajishengallis; Suzanne M Michalek
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

3.  Protective immunity against Streptococcus mutans infection in mice after intranasal immunization with the glucan-binding region of S. mutans glucosyltransferase.

Authors:  C Jespersgaard; G Hajishengallis; Y Huang; M W Russell; D J Smith; S M Michalek
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

4.  A phase IB trial of 24-hour intravenous PX-12, a thioredoxin-1 inhibitor, in patients with advanced gastrointestinal cancers.

Authors:  A F Baker; T Dragovich; K N Adab; N Raghunand; Hhs Chow; S P Stratton; S W Squire; M Boice; L A Pestano; D L Kirkpatrick
Journal:  Invest New Drugs       Date:  2012-06-19       Impact factor: 3.850

5.  The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma.

Authors:  Amanda F Baker; Tomislav Dragovich; Wendy R Tate; Ramesh K Ramanathan; Denise Roe; Chiu-Hsieh Hsu; D Lynn Kirkpatrick; Garth Powis
Journal:  J Lab Clin Med       Date:  2006-02

Review 6.  Thioredoxin in cancer--role of histone deacetylase inhibitors.

Authors:  Paul A Marks
Journal:  Semin Cancer Biol       Date:  2006-09-26       Impact factor: 15.707

7.  Toward a chemical marker for inflammatory disease: a fluorescent probe for membrane-localized thioredoxin.

Authors:  Min Hee Lee; Hyun Mi Jeon; Ji Hye Han; Nayoung Park; Chulhun Kang; Jonathan L Sessler; Jong Seung Kim
Journal:  J Am Chem Soc       Date:  2014-05-28       Impact factor: 15.419

8.  Thioredoxin mitigates radiation-induced hematopoietic stem cell injury in mice.

Authors:  Pasupathi Sundaramoorthy; Qinhong Wang; Zhihong Zheng; Yiqun Jiao; Benny J Chen; Phuong L Doan; Nelson J Chao; Yubin Kang
Journal:  Stem Cell Res Ther       Date:  2017-11-15       Impact factor: 6.832

9.  Effects of hexamethylene diisocyanate exposure on human airway epithelial cells: in vitro cellular and molecular studies.

Authors:  Adam V Wisnewski; Qing Liu; Jing-Jing Miller; Nadine Magoski; Carrie A Redlich
Journal:  Environ Health Perspect       Date:  2002-09       Impact factor: 9.031

Review 10.  Progress in L2-Based Prophylactic Vaccine Development for Protection against Diverse Human Papillomavirus Genotypes and Associated Diseases.

Authors:  Pola Olczak; Richard B S Roden
Journal:  Vaccines (Basel)       Date:  2020-10-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.